title: Antiviral therapy in patients with hepatitis B virus-related hepatocellular carcinoma: is it ready for universal application?
authors.affiliation: Department of Hepatobiliary Oncology, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China.
authors.forename: X-M
authors.initials: XM
authors.lastname: Lao
authors.forename: H H-X
authors.initials: HH
authors.lastname: Xia
authors.forename: X-J
authors.initials: XJ
authors.lastname: Lin
authors.forename: S-P
authors.initials: SP
authors.lastname: Li
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000601:surgery; D006498:Hepatectomy; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000601:surgery; D000077712:Telbivudine; D013936:Thymidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome; D014775:Virus Activation
chemical_list: D000998:Antiviral Agents; D000077712:Telbivudine; D013936:Thymidine